Cardiology Made Clearwith Dr. Freeman
For clinicians

CLINICIAN AFIB GUIDE · SECTION 2

An AFib patient in your clinic.
What should you do next?

Assess stability first. For a stable patient, address stroke prevention, ventricular rate control, and early EP referral.

FIRST: ASSESS STABILITY

Unstable or significantly symptomatic AFib with RVR? Arrange immediate hospital transport.

A patient with AFib and a rapid ventricular response (RVR) who is unstable or significantly symptomatic in clinic needs acute hospital management.

  • Signs of instability: hypotension with poor perfusion, altered mental status, syncope, ongoing ischemic chest discomfort, or acute heart failure/pulmonary edema.
  • Significant symptoms: severe or persistent dyspnea, chest discomfort, marked dizziness, or near-syncope with RVR require prompt hospital assessment, even when the blood pressure is preserved.
Call EMS for instability or severe symptoms.

Monitor and provide supportive care while awaiting transfer. Do not delay transport for outpatient medication adjustments or an EP appointment. The patient should not drive.

If AFib is causing hemodynamic instability, immediate synchronized electrical cardioversion is indicated in an appropriately equipped setting. A fast heart rate alone does not define instability; assess perfusion and symptoms.

FOR THE STABLE PATIENT

Three actions at the AFib encounter

Stroke prevention, rate control, and rhythm control address different problems. Controlling the pulse does not eliminate AFib or its stroke risk.

01

Assess stroke risk and start anticoagulation when indicated

1. Calculate CHA2DS2-VASc

Add the points for the patient’s stroke-risk factors. Count only one age category. Include the female-sex point in the total.

2. Start OAC at the recommended threshold

Men: score 2 or higher
OAC is recommended.

Women: score 3 or higher
OAC is recommended.

When this threshold is met, initiate an appropriate oral anticoagulant unless contraindicated, after reviewing bleeding concerns, renal function, interactions, and dose criteria.

Example: Hypertension (1) + diabetes (1) = 2 in a man. Adding the female-sex point gives 3 in a woman. Both meet the recommended threshold.

Intermediate risk: At 1 in men or 2 in women, OAC is reasonable after individualized discussion. Female sex alone does not justify OAC.

These thresholds apply to clinical AF/flutter. Device-detected episodes and other independent anticoagulation indications require their own assessment.

2023 ACC/AHA/ACCP/HRS AF guideline: anticoagulation recommendations

DOACs are preferred for eligible patients. Mechanical heart valves or moderate-to-severe mitral stenosis require a different anticoagulation approach, generally warfarin. Aspirin does not replace anticoagulation for AFib stroke prevention.

Base long-term stroke prevention on risk, regardless of AFib pattern or whether the patient is currently in sinus rhythm. If long-term anticoagulation cannot be tolerated, refer for assessment of left atrial appendage closure, such as Watchman.

02

Control the ventricular rate

Assess resting heart rate, blood pressure, symptoms, and possible heart failure. A beta blocker or diltiazem/verapamil may be appropriate depending on ventricular function and comorbidities; avoid diltiazem/verapamil with significant LV systolic dysfunction. Individualize the rate target and medication choice.

Rate control can improve symptoms and reduce the effects of sustained tachycardia. It does not restore normal atrial rhythm or replace stroke prevention.

03

Refer to EP early

Offer an EP consultation to patients with AFib, including after a first documented episode. Avoid waiting for progression or repeated medication failures before discussing a rhythm-control strategy.

EP can compare cardioversion, antiarrhythmic medication, and catheter ablation in the context of symptoms, disease stage, comorbidities, and patient preferences. Referral does not commit the patient to a procedure.

The clinic plan

Protect against stroke. Control the ventricular rate. Bring EP into the rhythm-control discussion early.

CLEAR DOCUMENTATION

Document the AFib pattern

Use the most accurate pattern rather than the nonspecific term “chronic AFib.”

Paroxysmal AFib

Episodes terminate within 7 days of onset, spontaneously or with intervention.

Persistent AFib

AFib continues for more than 7 days.

Long-standing persistent AFib

Continuous AFib for more than 12 months when rhythm control remains a treatment goal.

Permanent AFib

A shared decision has been made to accept AFib and stop attempts to restore or maintain sinus rhythm. This describes a treatment decision, not simply duration.

Example: “Persistent AFib, symptomatic, with controlled ventricular rate; CHA₂DS₂-VASc 3; anticoagulation addressed; referred to EP.” Document any mechanical valve or moderate-to-severe mitral stenosis because it changes anticoagulant selection.

INITIAL ASSESSMENT

Gather what helps the next decision

  • Confirm AFib on an EKG and record ventricular rate, symptoms, blood pressure, and approximate onset or duration.
  • Review medications, anticoagulant adherence, prior bleeding, and previous rhythm treatments.
  • Obtain CBC, metabolic panel including renal function/electrolytes, and thyroid testing when appropriate.
  • Address modifiable contributors such as hypertension, obesity, alcohol intake, and suspected sleep apnea.
  • Document the stroke prevention plan, rate-control plan, and EP referral.
Clinical source2023 ACC/AHA/ACCP/HRS atrial fibrillation guideline ↗

Updated October 10, 2026. Educational reference; use current guidelines and individual clinical judgment.